Company intelligence / Profile preview

Mefro

Wiesbaden, Germany

Ownership: Private
Development stage: Other

Overview

Mefro Pharm is a German pharmaceutical company focused on the development, manufacturing, and distribution of high-quality medicinal products. The company specializes in a range of therapeutic areas, including pain management and gastrointestinal health, offering both prescription and over-the-counter solutions. Mefro Pharm emphasizes reliable supply chains and adherence to stringent European quality standards to serve the healthcare market. Their portfolio includes established small molecule therapies designed to address common clinical needs in primary care.

Therapeutic areas: ImmunologyNeurologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Mefro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mefro.

Explore the full profile